Release Date: 31/01/19 18:52 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 699.59KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling